Zhitong Finance App News, *ST Pharmaceutical (600671.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 383.34 million yuan, an increase of 72.25% over the previous year; net loss attributable to shareholders of listed companies was 9.722,800 yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 10.7525 million yuan; basic loss per share.
*ST目药(600671.SH)发布一季度业绩，净亏损972.28万元
*ST Eye Medicine (600671.SH) announced first-quarter results with a net loss of 9.722,800 yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.